Drug Reference

Empagliflozin / Linagliptin / Metformin

Combinations of oral blood glucose lowering drugs

Fact box

Therapeutic class: Combinations of oral blood glucose lowering drugs

Brand names

Trijardy

Available as

10 MG · Extended Release Oral Tablet12.5 MG · Extended Release Oral Tablet25 MG · Extended Release Oral Tablet5 MG · Extended Release Oral Tablet

Multi-ingredient product

EmpagliflozinLinagliptinMetformin

This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.

Current FDA labels (DailyMed)

TRIJARDY XR (EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE) TABLET, EXTENDED RELEASE [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]

8 marketed products on record (RxNorm)

Authoritative sources

Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.